ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider James Kihara Sells 2,000 Shares

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Rating) insider James Kihara sold 2,000 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $24.15, for a total value of $48,300.00. Following the transaction, the insider now directly owns 9,144 shares of the company’s stock, […]

Related Keywords

United States ,America ,James Kihara ,Pharmaceuticals Company Profile ,Arete Wealth Advisors ,Acadia Pharmaceuticals Inc ,Pharmaceuticals Stock Performance ,Pharmaceuticals Inc ,Securities Exchange Commission ,Ameriprise Financial Inc ,Nasdaq ,International Biotechnology Trust ,Pharmaceuticals Daily ,Capital Impact Advisors ,Get Rating ,Exchange Commission ,Impact Advisors ,Wealth Advisors ,Biotechnology Trust ,Acadia Pharmaceuticals ,Nasdaq Acad ,Facad ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,